Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Porcine circovirus 2 immune protection polypeptide and vaccine comprising same

A porcine circovirus, immune protection technology, applied in the direction of viral peptides, viruses, antiviral agents, etc.

Active Publication Date: 2014-10-15
NANJING AGRICULTURAL UNIVERSITY
View PDF2 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] In order to solve the problem of whether the PCV2 Cap protein antigen has relevant immune protection in the above prior art, the invention provides a kind of porcine circovirus type 2 immune protection polypeptide

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Porcine circovirus 2 immune protection polypeptide and vaccine comprising same
  • Porcine circovirus 2 immune protection polypeptide and vaccine comprising same
  • Porcine circovirus 2 immune protection polypeptide and vaccine comprising same

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] According to the amino acid sequence of PCV2 Cap protein epitope and T cell epitope, the following 4 polypeptides were designed and synthesized by Shanghai Moxi Biotechnology Co., Ltd. with a purity of more than 90%.

[0029] : as shown in sequence 1 in the sequence table,

[0030] P5013: as shown in sequence 2 in the sequence listing,

[0031] P2914: as shown in sequence 3 in the sequence listing,

[0032] P1300: as shown in sequence 4 in the sequence listing.

[0033] 1.3 Vaccine preparation

[0034] Dissolve the synthetic peptide with a small amount of DMSO, add sterilized PBS buffer, adjust the protein concentration to 100 μg / mL, mix with ISA50V adjuvant in equal volume, emulsify into water-in-oil type, and store at 4 °C.

[0035] 2.1 Experimental animals and immunization procedures

[0036] Seventy-five 5-week-old clean ICR mice (Experimental Animal Center of Yangzhou University) were randomly divided into 5 groups with 15 mice in each group. Groups 1-4 were i...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
Login to View More

Abstract

The invention relates to the technical field of porcine circovirus, in particular to a porcine circovirus 2 (PCV2) immune protection polypeptide, and a vaccine containing the PCV2 immune protection polypeptide. The amino acid sequence of the PCV2 immune protection polypeptide is shown in the sequence table 1-4. According to the vaccine, tests show that after 42-63 days of first immune of a vaccine of P5013 and a vaccine of P1300, the antibody titer and the neutralizing antibody titer of an ELISA antibody are remarkably increased, the lymphocyte proliferative response and IL-4 and IFN-Gamma cytokines are significantly higher than those of a control group, and the antibody level and the cellular immunity level of the vaccine group of P5013 are the highest; mice tests show that PCV2 immune response induced by the synthetic peptide vaccine of P5013 is the highest and the strongest; pig tests find that the synthetic polypeptide vaccine of P5013 can induce pigs to generate a PCV2-specific immune response, can reduce viremia caused by PCV2 virulent virus attack, alleviate the clinical symptoms and pathological lesions of viremia, and has immune protection effect on PCV2.

Description

technical field [0001] The invention relates to the technical field of porcine circovirus, in particular to a porcine circovirus type 2 immune protection polypeptide and a vaccine prepared by using the porcine circovirus type 2 immune protection polypeptide. Background technique [0002] Porcine circovirus type 2 (Porcine circovirus 2, PCV2) is a member of the Circovirus genus of the family Circoviridae, which can cause a variety of diseases such as multisystemic wasting syndrome (PMWS) and porcine dermatitis nephropathy syndrome (PDNS) in weaned piglets. It has brought huge economic losses to the global pig industry. Cap protein is a type-specific antigen of PCV2, which has good immunogenicity, can effectively produce neutralizing antibodies through immunization, neutralize virus infection, and effectively induce protective immune responses against virus attack. At present, commercialized vaccines include inactivated PCV2 vaccine and inactivated PCV2 baculovirus vaccine,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/01A61K39/12A61P31/20
CPCA61K39/00C07K14/005C12N2750/10022C12N2750/10034
Inventor 姜平白娟
Owner NANJING AGRICULTURAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com